Remove 2015 Remove COPD Remove Outcomes
article thumbnail

Serial PoCUS for ED Patients with Acute Dyspnea: Is More Actually Better?

RebelEM

It can be used to distinguish between various conditions, including chronic obstructive pulmonary disease (COPD) exacerbation, acute heart failure (AHF), pleural effusion, pulmonary edema, pericardial effusion, pneumothorax, and pneumonia [2,3]. Patients : Compared standard of care to serial US plus stand care in patients with dyspnea.

article thumbnail

The Latest in Critical Care, 3/25/24 (Issue #35)

PulmCCM

In a well-randomized trial, equal numbers of clinically important differences in outcomes in opposite directions could average out to a null result, hiding the variability between patients. Neither PILOT nor ICU-ROX found a difference in outcomes with higher vs lower oxygenation targets in mechanical ventilated patients.

COPD 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

emDOCs Podcast – Episode 116: Massive Hemoptysis

EMDocs

Physiologic dead space higher in chronic lung disease (COPD). Poor candidates: underlying pulmonary disease like COPD, lung cancer, bronchiectasis. Hirshberg B, Biran I, Glazer M, Kramer MR. Hemoptysis: etiology, evaluation, and outcome in a tertiary referral hospital. 2015 Mar;45(3):756-64. Wide range in numbers for MH.

COPD 81
article thumbnail

REBEL Core Cast 122.0 – Neutropenic Fever

RebelEM

Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Volume 21, Issue 6, June 2015, Pages 583-590 Perron T, Emara M, Ahmed S. Time to antibiotics and outcomes in cancer patients with febrile neutropenia. Eur J Haematol 2005; 75:1. 2014;14:162.

article thumbnail

SGEM#346: Sepsis – You Were Always on My Mind

The Skeptics' Guide to EM

He has a history of chronic obstructive pulmonary disease (COPD), hypertension (HTN), congestive heart failure (CHF), and benign prostatic hypertrophy (BPH). All three showed no statistical difference between the two treatments for their primary outcome ( SGEM#69 , SGEM#92 and SGEM#113 ). He’s afebrile.

Sepsis 40